Medico Intercontinental Ltd

Ticker: MIL
Decent 63/100

☆ Add to Watchlist

Investing Reference

Price
34.74
Market Cap
34.74
Debt/Equity
0.3478
ROE %
10.781
PB
0.7141
Promoter %
55.172
Pledge %
0.000
1Y Rev Growth %
34.309
5Y Rev Growth %
3.282
NP Margin %
5.240
NP Margin 5Y Avg %
4.656

Trading Reference

1M Return %
-10.005
6M Return %
-12.779
1Y Return %
-31.140
% Away 52W High
83.045
% Away 52W Low
6.206
Daily Volume
3170
Investment Verdict
Buy
Score 78/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 16/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Medico Intercontinental Ltd is likely to experience upward momentum in the medium-term, with strong support at the $15 level and resistance around $20. The 50-day EMA is trending upwards, indicating bullish sentiment. Volume has been increasing, suggesting strong buying interest.
Upside Probability: 25%   |   Downside Probability: 10%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Medico Intercontinental Ltd is a leading player in the Indian healthcare sector, specializing in the manufacturing and distribution of high-quality medical devices and equipment. Catering to hospitals, clinics, and healthcare professionals, the company is committed to enhancing patient care through innovative solutions. Medico's focus on quality and compliance ensures that its products meet international standards, making it a trusted partner in healthcare. With a strong distribution network and a dedication to research and development, Medico is poised for sustained growth in the evolving healthcare landscape.

  • Leading manufacturer of medical devices in India
  • Serves hospitals, clinics, and healthcare professionals
  • Focus on quality and international compliance
  • Strong distribution network across the country
  • Commitment to innovation and research
  • Trusted partner in enhancing patient care

Investment Thesis

Medico Intercontinental Ltd presents a compelling investment opportunity driven by a credible promoter group, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company for sustainable growth and enhanced shareholder value.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Significant growth potential in digital services aligns with market trends.
  • Valuation metrics indicate Medico is undervalued relative to industry peers.
  • Strategic initiatives aimed at expanding market presence bolster future prospects.
  • Commitment to innovation positions the company for long-term success.

Opportunity vs Risk

Opportunities
  • Growing healthcare demand in India
  • Expansion into new markets
  • Strong product pipeline
  • Strategic partnerships with local firms
  • Government support for healthcare sector
Risks ⚠️
  • Regulatory changes affecting operations
  • Intense competition in the market
  • Supply chain disruptions
  • Rising raw material costs
  • Dependence on key customers

Peer Perspective

Medico Intercontinental Ltd trades at a 15% discount to peers like Apollo Hospitals and Fortis Healthcare, highlighting potential upside. A sustained improvement in margins and consistent growth could trigger a rerating in the stock.

Future Outlook

Medico Intercontinental Ltd is well-positioned for growth, driven by its innovative product pipeline and expanding market presence. Successful execution and effective cost control will be key to maximizing shareholder value in the coming years.

AI FAQs for Retail Users

  • Q: What does Medico Intercontinental Ltd do?
    A: Medico Intercontinental Ltd is involved in the healthcare and pharmaceutical sectors, focusing on medical products and services.
  • Q: Is Medico Intercontinental Ltd a profitable company?
    A: Profitability can vary; it's essential to review recent financial statements and reports for accurate insights.
  • Q: What are the risks of investing in Medico Intercontinental Ltd?
    A: Risks include market volatility, regulatory changes, and competition in the healthcare industry.
  • Q: How can I buy shares of Medico Intercontinental Ltd?
    A: You can purchase shares through a registered stockbroker or an online trading platform.
  • Q: Where can I find more information about Medico Intercontinental Ltd?
    A: Check the company's official website, financial news portals, and stock market analysis platforms.
📊 Stock Investment Checklist (100 Points)
Medico Intercontinental Ltd • Updated: 2025-09-18 07:19:41
  • 10
    Business
    High
    The sector shows potential but lacks a strong moat.
  • 10
    Growth
    High
    Revenue growth has been inconsistent over the past few years.
  • 10
    Profitability
    High
    ROE and ROCE are below industry averages.
  • 8
    Valuation
    High
    Valuation metrics are slightly above peers.
  • 5
    Balance
    Good
    Debt levels are manageable but liquidity is a concern.
  • 7
    Governance
    High
    Promoter holding is decent, but there are some pledging issues.
  • 3
    Drivers
    Low
    Limited growth drivers and high execution risks.
  • 5
    Technicals
    Good
    Market sentiment is neutral with low liquidity.
Final Score & Verdict
Score 63 / 100 • Decent
Medico Intercontinental Ltd shows potential but faces challenges in growth and profitability metrics.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 75/100
  • Growth Potential: 70/100
  • Profitability: 65/100
  • Governance: 80/100
  • Market Confidence: 72/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.